← FDA Drug Approvals (Drugs@FDA)

LAMISIL

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2007-09-28

Drug application

FDA Application #

NDA022071

Application type

New Drug Application

Brand name

LAMISIL

Generic name

Terbinafine Hydrochloride

Active ingredients

TERBINAFINE HYDROCHLORIDE

Dosage form

GRANULE

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

2007-09-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown